UB Paderborn / Katalog / Suche / in CDI

Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide

Nature communications, 2019-02, Vol.10 (1), p.763-763, Article 763

2019

Volltextzugriff (PDF)

Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C

PLoS pathogens, 2016-09, Vol.12 (9), p.e1005864-e1005864

2016

Volltextzugriff (PDF)

Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens

Proceedings of the National Academy of Sciences - PNAS, 2015-09, Vol.112 (38), p.11947-11952

2015

Volltextzugriff (PDF)

HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry

Virology (New York, N.Y.), 2007-04, Vol.361 (1), p.212-228

2007

Volltextzugriff (PDF)

The CCR5 and CXCR4 coreceptors: Central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection

AIDS research and human retroviruses, 2004, Vol.20 (1), p.111-126

2004

Volltextzugriff (PDF)

A novel anti‐inflammatory treatment for bradykinin‐induced sore throat or pharyngitis

Immunity, Inflammation and Disease, 2021-12, Vol.9 (4), p.1321-1335

2021

Volltextzugriff (PDF)

Conformation-Dependent Recognition of HIV gp120 by Designed Ankyrin Repeat Proteins Provides Access to Novel HIV Entry Inhibitors

Journal of Virology, 2013-05, Vol.87 (10), p.5868-5881

2013

Volltextzugriff (PDF)

A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV

PloS one, 2014-04, Vol.9 (4), p.e94547

2014

Volltextzugriff (PDF)

A Modified Zinc Acetate Gel, a Potential Nonantiretroviral Microbicide, Is Safe and Effective against Simian-Human Immunodeficiency Virus and Herpes Simplex Virus 2 Infection In Vivo

Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.4001-4009

2013

Volltextzugriff (PDF)

Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors

Virology (New York, N.Y.), 2008-08, Vol.377 (2), p.401-407

2008

Volltextzugriff (PDF)

Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 Inhibitor

Journal of Virology, 2004-03, Vol.78 (6), p.2790-2807

2004

Volltextzugriff (PDF)

HIV-1 Escape from a Small Molecule, CCR5-Specific Entry Inhibitor Does Not Involve CXCR4 Use

Proceedings of the National Academy of Sciences - PNAS, 2002-01, Vol.99 (1), p.395-400

2002

Volltextzugriff (PDF)

Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities

Virology (New York, N.Y.), 2009-05, Vol.387 (2), p.296-302

2009

Volltextzugriff (PDF)

In vivo binding and retention of CD4-specific DARPin 57.2 in macaques

PloS one, 2010-08, Vol.5 (8), p.e12455

2010

Volltextzugriff (PDF)

The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4

Virology (New York, N.Y.), 2004-03, Vol.321 (1), p.8-22

2004

Volltextzugriff (PDF)

Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike

Nature (London), 2017-07, Vol.547 (7663), p.360-363

2017

Volltextzugriff (PDF)

A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene

Journal of virology, 2015-03, Vol.89 (6), p.3380-3395

2015

Volltextzugriff (PDF)

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface

Nature (London), 2014-11, Vol.515 (7525), p.138-142

2014

Volltextzugriff (PDF)

Inhibition of Bacterial Superantigens by Peptides and Antibodies

Infection and Immunity, 2001-02, Vol.69 (2), p.875-884

2001

Volltextzugriff (PDF)

HIV-1 neutralizing antibodies induced by native-like envelope trimers

Science (American Association for the Advancement of Science), 2015-07, Vol.349 (6244), p.154-154

2015

Volltextzugriff (PDF)

The Differential Sensitivity of Human and Rhesus Macaque CCR5 to Small-Molecule Inhibitors of Human Immunodeficiency Virus Type 1 Entry Is Explained by a Single Amino Acid Difference and Suggests a Mechanism of Action for These Inhibitors

Journal of Virology, 2004-04, Vol.78 (8), p.4134-4144

2004

Volltextzugriff (PDF)

Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes

Journal of virology, 2019-02, Vol.93 (4)

2019

Volltextzugriff (PDF)

Native Conformation and Canonical Disulfide Bond Formation Are Interlinked Properties of HIV-1 Env Glycoproteins

Journal of virology, 2015-12, Vol.90 (6), p.2884-2894

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide

Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C

Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens

HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry

The CCR5 and CXCR4 coreceptors: Central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection

A novel anti‐inflammatory treatment for bradykinin‐induced sore throat or pharyngitis

Conformation-Dependent Recognition of HIV gp120 by Designed Ankyrin Repeat Proteins Provides Access to Novel HIV Entry Inhibitors

A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV

A Modified Zinc Acetate Gel, a Potential Nonantiretroviral Microbicide, Is Safe and Effective against Simian-Human Immunodeficiency Virus and Herpes Simplex Virus 2 Infection In Vivo

Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors

Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 Inhibitor

HIV-1 Escape from a Small Molecule, CCR5-Specific Entry Inhibitor Does Not Involve CXCR4 Use

Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities

In vivo binding and retention of CD4-specific DARPin 57.2 in macaques

The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4

Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike

A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface

Inhibition of Bacterial Superantigens by Peptides and Antibodies

HIV-1 neutralizing antibodies induced by native-like envelope trimers

The Differential Sensitivity of Human and Rhesus Macaque CCR5 to Small-Molecule Inhibitors of Human Immunodeficiency Virus Type 1 Entry Is Explained by a Single Amino Acid Difference and Suggests a Mechanism of Action for These Inhibitors

Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes

Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes

Native Conformation and Canonical Disulfide Bond Formation Are Interlinked Properties of HIV-1 Env Glycoproteins

Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization

Suchergebnisse filtern